Mindfulness to Improve Functional Outcomes in Patients With Fibromyalgia or Central Sensitization

Chronic Pain Clinical Trial

Official title: Mindfulness to Improve Functional Outcomes in Patients With Fibromyalgia or Central Sensitization: A Pilot Feasibility Study

Status Terminated

Clinical Trial Summary

The primary aim of the study will be to determine the feasibility of utilizing a web-based mindfulness program in adult patients with chronic pain with a diagnosis of fibromyalgia or central sensitization.

Clinical Trial Description

Chronic pain has a substantial economic cost and rate of impairment. Patients who suffer from fibromyalgia and other pain conditions leading to central sensitization have limited treatment options. The only medications currently approved by the Food and Drug Administration (FDA) for the treatment of fibromyalgia includes pregabalin, milnacipran and duloxetine. The International Association for the Study of Pain (IASP) also recommends the implementation of an exercise program and cognitive behavioral therapy. A previous meta-analysis found weak evidence to support Mindfulness-Based Stress Reductions (MBSR) in fibromyalgia patients, however more robust clinical studies are needed. In the midst of an opioid crisis, MBSR provides a safer alternative for the treatment of chronic pain. Unfortunately, an instructor lead MBSR program is both costly and largely unavailable in rural areas of the country. This web-based mindfulness program provides a treatment option for patients who would otherwise, not have access to alternative medicine therapies. ;

Related Conditions & MeSH terms

• Central Sensitisation
• Chronic Pain
• Fibromyalgia
• Myofascial Pain Syndromes

• NCT number: NCT03693274
• Study type: Interventional
• Source: Vanderbilt University Medical Center
• Status: Terminated
• Phase: N/A
• Start date: January 2, 2019
• Completion date: August 25, 2020